Federated Hermes’s Alpine Immune Sciences Inc ALPN Stock Holding History

Federated Hermes’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-138,981	Closed	-$5.51M	–	2167
2024 Q1	$5.51M	Buy	138,981 +138,616	+37,977%	+$4.09M	0.01%	707
2023 Q4	$6.96K	Buy	+365	New	+$5.07K	﹤0.01%	1823
2021 Q1	–	Sell	-236	Closed	-$3K	–	2369
2020 Q4	$3K	Buy	236 +206	+687%	+$2.02K	﹤0.01%	2106
2020 Q3	$1K	Buy	+30	New	+$274	﹤0.01%	2210
2015 Q4	–	Sell	-27,534	Closed	-$1.43M	–	2167
2015 Q3	$1.43M	Sell	27,534 -9,966	-27%	-$655K	﹤0.01%	990
2015 Q2	$2.27M	Buy	+37,500	New	+$2.23M	0.01%	886

Federated Hermes's ALPN Position: Q2 2024 in Review

Federated Hermes sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 138,981 shares — an estimated $5.51M sold.

Federated Hermes first reported a position in ALPN in Q2 2015 and held it in 6 quarters. The position peaked at $5.51M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Federated Hermes reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Federated Hermes sold 138,981 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $5.51M.
Federated Hermes first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 6 quarters.
Federated Hermes's Alpine Immune Sciences Inc position peaked at $5.51M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.